Nick talks to Jeff Ubserax, PhD, CEO of the biotechnology company Demetrix (who supported this episode). Jeff discussed the science behind how Demetrix is engineering baker's yeast to produce cannabinoids at an industrial scale, with a focus on making rare cannabinoids other than THC and CBD.
Jeff also discussed how he transitioned from academic science to running his own company, and offered advice for academic scientists in training who might be thinking about moving into biotechnology.
USEFUL LINKS:
Download the podcast & follow Nick at his website
[www.nickjikomes.com]
Support the show on Patreon & get early access to episodes
[https://www.patreon.com/nickjikomes]
Sign up for the weekly Mind & Matter newsletter
[http://eepurl.com/hFlc7H]
Try MUD/WTR, a mushroom-based coffee alternative
[https://www.mudwtr.com/mindmatter]
Discount Code ($5 off) = MINDMATTER
Organize your digital highlights & notes w/ Readwise (2 months free w/ subscription)
[https://readwise.io/nickjikomes/]
Start your own podcast (get $20 Amazon gift card after signup)
[https://www.buzzsprout.com/?referrer_id=1507198]
Buy Mind & Matter T-Shirts
[https://www.etsy.com/shop/OURMIND?ref=simple-shop-header-name&listing_id=1036758072§ion_id=34648633]
Connect with Nick Jikomes on Twitter
[https://twitter.com/trikomes]
Learn more about our podcast sponsor, Dosist
[https://dosist.com/]
ABOUT Nick Jikomes:
Nick is a neuroscientist and podcast host. He is currently Director of Science & Innovation at Leafly, a technology startup in the legal cannabis industry. He received a Ph.D. in Neuroscience from Harvard University and a B.S. in Genetics from the University of Wisconsin-Madison.
Support the show (https://www.patreon.com/nickjikomes)
